VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ILMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ILMNIllumina, Inc.
$190.89$28.9B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksILMNBalance Sheet

Illumina, Inc. (ILMN) Balance Sheet

27Y historyFree accessUpdated daily

Leverage has improved markedly, with D/E falling to 0.89 from 2.03 in Q2 2024, and equity nearly doubling to $2.8B, though goodwill of $1.3B remains a potential overstatement.

ILMN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Jan'23Jan'22Jan'21Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Total Current Assets2.83B3.29B2.75B2.61B3.56B2.71B4.48B4.45B4.49B2.98B2.32B2.1B1.89B1.62B1.79B1.54B1.26B981.59M864.94M562.75M193.73M79.71M83.69M40.42M72.82M96.26M129.07M33.49M
Cash & Short-Term Investments1.17B1.63B1.22B1.05B2.04B1.34B3.47B3.41B3.51B2.15B1.56B1.39B1.34B1.17B1.35B1.19B894.29M693.53M640.08M386.08M130.8M50.82M54.79M32.78M53.76M90.49M117.1M33.09M
Cash Only1.04B1.42B1.13B1.05B2.01B1.23B1.81B2.04B1.14B1.23B734.52M768.77M636.15M711.64M433.98M302.98M248.95M144.63M327.02M174.94M38.39M50.82M54.79M12.46M2.04M4.17M116.1M21.16M
Short-Term Investments128M215M93M6M26M107M1.66B1.37B2.37B920M824.21M617.45M702.22M453.97M916.22M886.59M645.34M548.89M313.05M211.14M92.42M0020.32M51.73M86.33M1M11.92M
Accounts Receivable764M854M751M752M688M664M487M573M514M411M381.32M385.53M289.46M238.95M214.97M173.89M165.6M157.75M133.27M83.12M39.98M17.62M11.89M4.8M3.73M1.27M0308.94K
Days Sales Outstanding63.171.8662.760.9454.7853.5554.8859.0356.2954.5158.0363.3956.7661.3768.3260.1366.9686.4184.8682.7179.0687.585.862.47135.64185.88-237.88
Inventory629M564M547M587M568M431M372M359M386M333M300.17M270.78M191.14M154.1M158.72M128.78M142.21M92.78M73.43M53.98M20.17M10.31M3.81M2.02M2.3M971K00
Days Inventory Outstanding146.42142.46132.13121.74128.61114.66131.06121.78136.39131.26149.67147.29123.78110.44154.49135.68172.33164.57130.35148.77124.05162.32104.873.53237.31636.29--
Other Current Assets273M238M228M216M268M0152M105M78M91M77.88M54.3M70.63M58.89M30.45M52.38M56.3M20.02M18.16M26.93M2.77M959K999K100K12.53M3.29M11.96M95.83K
Total Non-Current Assets3.82B3.35B3.56B7.5B8.69B12.5B3.1B2.87B2.47B2.28B1.96B1.59B1.45B1.4B779.04M651.22M580.72M448.35M512.16M424.98M106.86M20.9M11.22M58.82M49.09M26.2M3.73M401.61K
Property, Plant & Equipment1.11B1.13B1.23B1.55B1.74B1.7B1.45B1.44B1.07B931M713.33M342.69M265.26M202.67M166.17M143.48M129.87M117.19M89.44M46.27M25.63M16.13M8.57M45.78M48.28M25.97M3.29M291.31K
Fixed Asset Turnover4.00x3.84x3.54x2.90x2.63x2.67x2.23x2.45x3.10x2.96x3.36x6.48x7.02x7.01x6.91x7.36x6.95x5.69x6.41x7.93x7.20x4.56x5.90x0.61x0.21x0.10x0.40x1.63x
Goodwill1.28B1.11B1.11B2.54B3.24B7.11B897M824M831M771M776M752.63M724.9M723.06M369.33M321.85M278.21M213.45M228.73M228.73M2.13M2.13M000000
Intangible Assets410M210M295M2.99B3.29B3.25B142M145M185M175M242.65M273.62M314.5M331.17M130.2M106.47M70.02M43.79M47.76M57.97M108K59K11.89M848K786K037.87K75.73K
Long-Term Investments994M338M227M196M211M213M418M283M260M266M57.4M56.6M37.2M22.1M045.3M32M055.9M067.78M0012.19M0-29K00
Other Non-Current Assets576M111M121M217M212M232M171M105M48M46M49.81M30.86M58.32M33.99M73.16M14.44M31.11M26.55M12.02M11.75M11.21M2.58M012.19M22K262K398.77K34.57K
Total Assets6.65B6.64B6.3B10.11B12.25B15.22B7.58B7.32B6.96B5.26B4.28B3.69B3.34B3.02B2.57B2.2B1.84B1.43B1.38B987.73M300.58M100.61M94.91M99.23M121.91M122.47M132.79M33.89M
Asset Turnover0.69x0.65x0.69x0.45x0.37x0.30x0.43x0.48x0.48x0.52x0.56x0.60x0.56x0.47x0.45x0.48x0.49x0.47x0.42x0.37x0.61x0.73x0.53x0.28x0.08x0.02x0.01x0.01x
Asset Growth %23.47%5.41%-37.66%-17.47%-19.48%100.62%3.68%5.13%32.38%22.81%16.08%10.5%10.55%17.65%16.86%19.4%28.62%3.84%39.42%228.6%198.76%6.01%-4.36%-18.6%-0.46%-7.78%291.78%-
Total Current Liabilities1.58B1.58B1.55B1.57B2.77B1.09B1.24B665M1.8B746M704.66M610.49M722.16M322.06M304.57M237.58M534.52M441.24M509.56M165.72M33.78M21.72M19.05M8.19M14.3M4.81M2.81M612.41K
Accounts Payable230M240M221M245M293M332M192M149M184M160M138M139.23M82.63M73.66M65.73M49.81M66.74M52.78M29.2M24.31M9.85M7.39M2.68M7.57M1.77M1.98M727K318.22K
Days Payables Outstanding55.4160.6253.3950.8166.3488.3267.6450.5465.0163.0768.8175.7353.5152.7963.9852.4780.8893.6251.846760.6116.3673.89275.29182.711.29K-666.72-1.21K
Short-Term Debt500M499M578M01.25B0562M45M1.11B10M1.25M74.93M304.26M29.29M36.97M0311.61M290.2M400M16K63K118K0619K677K297K261K1.5K
Deferred Revenue (Current)1.03B270M260M252M245M234M186M167M175M130M120.62M96.65M75.29M50.83M69.58M52.57M45.86M015.86M7.54M000010.01M10.05M00
Other Current Liabilities10M249M70M223M188M241M83M64M63M219M301.02M134.86M108.43M55.15M70M53.17M47.66M024.71M90.54M13.82M8.35M11.64M-5.54M001.82M292.69K
Current Ratio1.80x2.08x1.78x1.66x1.28x2.48x3.60x6.69x2.49x3.99x3.29x3.43x2.62x5.02x5.87x6.50x2.35x2.22x1.70x3.40x5.74x3.67x4.39x4.94x5.09x20.02x45.99x54.69x
Quick Ratio1.40x1.72x1.42x1.29x1.08x2.09x3.30x6.15x2.27x3.55x2.86x2.99x2.35x4.54x5.35x5.96x2.09x2.01x1.55x3.07x5.14x3.20x4.19x4.69x4.93x19.82x45.99x54.69x
Cash Conversion Cycle154.11153.7141.45131.87117.0579.89118.3130.27127.66122.7138.89134.95127.03119.02158.83143.34158.41157.36163.36164.48142.51133.46116.72-139.29190.24-472.04--
Total Non-Current Liabilities2.23B2.34B2.38B2.8B2.88B3.38B1.65B2.04B1.31B1.67B1.31B1.23B1.15B1.16B942.93M883.04M106.92M124.45M18.95M410.34M19.47M6.39M3.6M43.66M35.87M10.87M5.89M1.25M
Long-Term Debt1.49B1.49B1.49B1.49B1.49B1.7B673M1.14B890M1.18B1.05B1.02B986.78M839.59M805.41M813.09M78.39M00400M054K025M25.37M590K886.63K0
Capital Lease Obligations1.92B486M554M687M744M774M671M695M269M0000000000000000000
Deferred Tax Liabilities0000000000000000047.37M080.25M6.99M0000000
Other Non-Current Liabilities289M360M272M620M649M915M259M160M359M360M213.95M180.5M167.9M324.15M137.53M80.61M28.53M77.08M16.63M10.34M10.01M3.5M379K18.66M10.5M10.28M5M1.25M
Total Liabilities3.81B3.92B3.93B4.37B5.65B4.48B2.89B2.7B3.05B2.29B1.97B1.81B1.88B1.49B1.25B1.12B641.44M565.69M528.5M576.05M53.24M28.11M22.64M51.85M50.16M15.67M8.69M1.86M
Total Debt2.53B2.55B2.62B2.26B3.56B2.54B1.91B1.88B2B1.19B1.05B1.09B1.29B868.88M842.37M813.09M390M290.2M400M400.02M63K172K025.62M26.3M887K1.15M1.5K
Net Debt1.49B1.14B1.5B1.21B1.54B1.31B96M-161M853M-33M314.54M321.81M654.88M157.24M408.39M510.11M141.05M145.57M72.97M225.07M-38.32M-50.65M-66.99M13.15M24.26M-3.28M-114.95M-21.16M
Debt / Equity0.89x0.94x1.10x0.39x0.54x0.24x0.41x0.41x0.51x0.39x0.45x0.58x0.88x0.57x0.64x0.76x0.33x0.34x0.47x0.97x0.00x0.00x-0.54x0.37x0.01x0.01x0.00x
Debt / EBITDA2.08x2.25x---19.84x2.49x1.60x1.88x1.56x1.44x1.47x2.06x3.74x3.17x3.03x1.54x1.85x3.70x-0.00x-------
Net Debt / EBITDA1.22x1.00x---10.22x0.13x-0.14x0.80x-0.04x0.43x0.43x1.04x0.68x1.53x1.90x0.56x0.93x0.67x--0.88x-------
Interest Coverage14.53x11.75x-10.79x-13.51x-165.77x15.49x18.47x22.50x16.68x29.19x18.00x14.56x11.75x5.01x6.89x4.82x8.54x5.81x4.27x---------
Total Equity2.84B2.72B2.37B5.75B6.6B10.74B4.69B4.61B3.93B3.06B2.34B1.88B1.46B1.53B1.32B1.08B1.2B864.25M848.6M411.68M247.34M72.5M72.26M47.39M71.74M106.79M124.1M32.03M
Equity Growth %65.49%14.75%-58.69%-12.94%-38.56%128.8%1.76%17.32%28.33%30.76%24.57%28.6%-4.59%16.28%22.63%-10.22%38.58%1.84%106.13%66.44%241.18%0.33%52.49%-33.95%-32.82%-13.95%287.42%-
Book Value per Share18.5517.4614.9236.3642.0371.1331.7230.9626.3920.7015.8312.629.8210.969.867.748.356.306.353.802.540.901.010.741.161.792.2311.36
Total Shareholders' Equity2.84B2.72B2.37B5.75B6.6B10.74B4.69B4.61B3.85B2.84B2.27B1.85B1.46B1.53B1.32B1.08B1.2B864.25M848.6M411.68M247.34M72.5M72.26M47.39M71.74M106.79M124.1M32.03M
Common Stock2M2M2M2M2M2M2M2M2M2M1.89M1.86M1.8M1.75M1.7M1.67M1.52M1.44M1.39M628K469K413K381K329K325K322K319.65K51.39K
Retained Earnings-51M-392M-1.24B-19M1.14B5.49B4.72B4.07B3.08B2.26B1.49B1.02B561.21M207.85M82.55M-68.71M-155.34M-280.23M-332.5M-382.98M-104.62M-144.59M-123.71M-117.49M-90.42M-50.09M-25.27M-6.66M
Treasury Stock-5.05B-4.7B-3.93B-3.79B-3.75B-3.7B-3.85B-3.02B-2.62B-2.34B-2.02B-1.67B-1.27B-1.24B-1.19B-1.11B-541.56M-497.54M-322.41M-251.62M00000000
Accumulated OCI8M-10M22M-1M3M17M2M5M-1M-1M-1.04M36K-1.08M1.23M2.12M2.12M1.76M2.83M2.41M1.35M11.29M-96K-60K-768K-2.64M-7.33M-14.03M-4.04M
Minority Interest0000000087M220M73.01M32.55M0000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Competitive pricing pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Easing as Losses Narrow

Illumina's balance sheet is deleveraging, with D/E falling from 2.03 in Q2 2024 to 0.89 by Q2 2026, as reported in quarterly filings, while equity nearly doubled to $2.8B.

The sharp reduction in leverage coincides with the GRAIL divestiture and improved profitability, as retained earnings moved from a -$2.1B deficit to -$51M. This suggests the balance sheet is recovering from the GRAIL-related losses, though the negative retained earnings still indicate accumulated losses that will take time to rebuild. The trajectory appears positive, but the pace of improvement may slow as the company transitions to a more stable growth phase.

Debt Burden Lightens Post-GRAIL

Total debt declined from $2.9B in Q2 2024 to $2.5B by Q2 2026, with D/E improving from 2.03 to 0.89, according to balance sheet data, reflecting debt reduction and equity growth.

The debt reduction is modest in absolute terms, but the improvement in D/E is significant, driven by both lower debt and higher equity. This suggests the company is managing its leverage prudently after the GRAIL episode, though the absolute debt level remains substantial at $2.5B. The interest coverage is not directly visible, but the improved profitability should support debt service, and the company appears to have adequate capacity to refinance if needed.

Asset Base Stabilizes with Lower Intangibles

Total assets have stabilized around $6.7B, with goodwill declining from $2.5B in Q1 2024 to $1.3B by Q2 2026, as reported in financial statements, reflecting the GRAIL divestiture.

The reduction in goodwill suggests that the GRAIL divestiture removed a significant intangible asset, reducing potential impairment risk. PPE has remained relatively flat at $1.1B, indicating a stable asset base for manufacturing operations. The asset mix now appears more focused on core sequencing assets, which may improve asset turnover and reduce the risk of future write-downs.

Equity Rebuilds as Losses Subside

Shareholders' equity nearly doubled from $1.4B in Q2 2024 to $2.8B by Q2 2026, with retained earnings improving from -$2.1B to -$51M, based on reported figures, signaling a return to profitability.

The improvement in equity is primarily driven by the swing to profitability, as retained earnings deficits have been largely eliminated. However, the company has also been active in share repurchases, which may have offset some equity growth. The negative retained earnings still indicate that the company has not fully recovered from past losses, but the trend is clearly positive. Investors should monitor whether the company continues to buy back shares or shifts to debt reduction.

Liquidity Buffer Remains Adequate

Current ratio improved to 1.80 in Q2 2026 from 1.11 in Q2 2024, with cash at $1.0B, as per balance sheet data, providing a reasonable buffer against short-term obligations.

The current ratio has fluctuated but remains above 1.5 in recent quarters, indicating sufficient short-term liquidity. Cash levels have been relatively stable around $1B, which, combined with operating cash flow, provides a cushion for working capital needs and potential investments. However, the company's debt load of $2.5B means that liquidity is not excessive, and the company may need to manage its cash carefully to meet debt obligations and fund ongoing operations.

Deferred Revenue Signals Stable Demand

Deferred revenue has remained relatively stable, ranging from $238M to $329M over the past ten quarters, with Q2 2026 at $261M, as reported in financial statements, suggesting consistent demand for services.

The stability in deferred revenue indicates that the company is not experiencing significant swings in advance payments, which may reflect a steady stream of service contracts and consumable orders. While the slight decline from the peak of $329M in Q1 2025 could suggest a softening in demand, the overall range is narrow, implying that the business is not facing a sharp deterioration. This provides some forward visibility into near-term revenue, though the metric is not a major driver for the company.

Goodwill and Debt Distort True Leverage

Despite a reported D/E of 0.89, the balance sheet may be more leveraged than it appears, as goodwill of $1.3B and potential off-balance-sheet obligations are not fully captured, according to analyst interpretation.

The reported D/E of 0.89 is based on total debt, but this may understate the company's true leverage if there are operating leases or other off-balance-sheet items. Additionally, the goodwill of $1.3B, while reduced, still represents a significant intangible asset that could be impaired if the core business underperforms. Investors should also consider the impact of stock-based compensation, which can dilute equity over time, and the potential for legal contingencies related to the GRAIL divestiture. These factors suggest that the headline leverage metrics may not fully reflect the financial risk.

ILMN — Frequently Asked Questions

Quick answers to the most common questions about buying ILMN stock.

What are the total assets of Illumina, Inc. (ILMN)?

As of 2025, Illumina, Inc. (ILMN) had total assets of $6.64B including $3.29B in current assets.

How much debt does Illumina, Inc. (ILMN) have?

Illumina, Inc. (ILMN) carries total debt of $2.55B, offset by $1.63B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Illumina, Inc.?

Illumina, Inc. (ILMN) has total shareholders' equity (book value) of $2.72B ($17.46 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Illumina, Inc.'s current ratio and liquidity?

Illumina, Inc. (ILMN) reported a current ratio of 2.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.